Eric Falcand
Chief Executive Officer chez Neopharmed Gentili SpA
Profil
Eric Falcand is currently the Chief Executive Officer at Neopharmed Gentili SpA.
He also holds positions as Vice President & Head of Business Development at Servier Laboratories and General Manager at Servier CJSC.
Previously, he served as the Chief Executive Officer at Servier IP UK Ltd.
and as an Independent Director at GeNeuro SA (Switzerland).
He was also the Head of Sales Division at Synthélabo SA from 1991 to 1997 and the Head of Business Development & Licensing at Servier Monde SAS.
Dr. Falcand has an MBA from EM Lyon Business School, a doctorate from Ecole Nationale Vétérinaire de Nantes, and a graduate degree from Institut de Pharmacie Industrielle de Lyon.
Postes actifs de Eric Falcand
Sociétés | Poste | Début |
---|---|---|
Servier CJSC
Servier CJSC Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The private company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases. | Corporate Officer/Principal | - |
Servier Laboratories
Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | Corporate Officer/Principal | - |
Neopharmed Gentili SpA
Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | Chief Executive Officer | 07/11/2023 |
Anciens postes connus de Eric Falcand
Sociétés | Poste | Fin |
---|---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Sales & Marketing | 01/01/1997 |
Servier Monde SAS
Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Servier Monde SAS provides legal services. The company is headquartered in Suresnes, France. | Corporate Officer/Principal | - |
Servier IP UK Ltd.
Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a private company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Chief Executive Officer | - |
GENEURO SA | Director/Board Member | - |
Formation de Eric Falcand
EM Lyon Business School | Masters Business Admin |
Ecole Nationale Vétérinaire de Nantes | Doctorate Degree |
Institut de Pharmacie Industrielle de Lyon | Graduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Sociétés cotées | 1 |
---|---|
GENEURO SA | Health Technology |
Entreprise privées | 6 |
---|---|
Synthélabo SA
Synthélabo SA Pharmaceuticals: OtherHealth Technology Synthelabo was a pharmaceutical company which was focused on cardiovascular disease/thrombosis, disorders of central nervous system, oncology and internal medicine. The company was headquartered in Le Plessis-Robinson, France. | Health Technology |
Servier Monde SAS
Servier Monde SAS Miscellaneous Commercial ServicesCommercial Services Servier Monde SAS provides legal services. The company is headquartered in Suresnes, France. | Commercial Services |
Neopharmed Gentili SpA
Neopharmed Gentili SpA Pharmaceuticals: MajorHealth Technology Neopharmed Gentili SpA is a holding company, which engages in the production and sale of pharmaceutical products. the firm includes development and marketing of therapeutic solutions in vascular, cardio-metabolic, respiratory, antibiotic, and over-the-counter medications. Its products include drugs, medical devices, food supplements, and cosmetics. The company was founded in 2009 and is headquartered in Milan, Italy. | Health Technology |
Servier IP UK Ltd.
Servier IP UK Ltd. Medical DistributorsDistribution Services Part of Baxter International, Inc., Servier IP UK Ltd. is a private company that wholesales pharmaceutical products. Servier IP UK Ltd. is based in Slough, UK. Servier IP was acquired by Baxter International, Inc. from Essetifin SpA on July 23, 2015 for $1,255.92 million. | Distribution Services |
Servier Laboratories
Servier Laboratories Pharmaceuticals: MajorHealth Technology Servier Laboratories operates as a French pharmaceutical company. The private company is based in Paris, France and has subsidiaries in Belgium. | Health Technology |
Servier CJSC
Servier CJSC Miscellaneous Commercial ServicesCommercial Services Part of Servier SAS, Servier CJSC is a Russian international pharmaceutical company that produces original medicines for the treatment of various diseases. The private company is based in Rostov, Russian Federation. The company operates in 149 countries and has more than 20,000 employees. Servier is the second largest French pharmaceutical company in the world and manages by a non-profit foundation. The company's focus is on cardiovascular diseases, chronic venous diseases, oncology, diabetes mellitus, neuropsychiatric, and other diseases. | Commercial Services |